Статті-сироти

Перейти до: навігація, пошук

На такі сторінки нема посилань з інших сторінок і вони не включаються до інших сторінок HistoryPedia.

Нижче показано до 50 результати у діапазоні від #110 791 до #110 840.

Переглянути (попередні 50наступні 50) (2050100250500).

  1. To Those People Who Wish To Gain Knowledge Of Duvelisib But Struggles To Get Started
  2. To Those People Who Wish To Grasp S1PR1 But Are Unable To Get Rolling
  3. To Those People Who Wish To Learn Ipatasertib But Finding It Difficult To Get Going
  4. To Those People Who Wish To Master Adriamycin But Cannot Move On
  5. To Those People Who Wishes To Grasp Quetiapine But Struggles To Move On
  6. To Those People Who Wishes To Learn 3-mercaptopyruvate sulfurtransferase But Simply Cannot Move On
  7. To Those People Who Wishes To Master UNC2881 But Find It Difficult To Get Started
  8. To Those People Who Would Like To Become Skilled At Roxadustat But Aren't Able To Move On
  9. To Those Who Want To Gain Knowledge Of UGT1A7 But Can't Move On
  10. To Those Who Want To Grasp Histone demethylase But Can't Get Going
  11. To Those Who Want To Master EX 527 But Aren't Able To Get Going
  12. To Those Who Wants To Become Skilled At Q-VD-Oph But Are Unable To Get Going
  13. To Those Who Wants To Gain Knowledge Of Trichostatin A But Find It Difficult To Move On
  14. To Those Who Wants To Grasp Fulvestrant But Just Can't Move On
  15. To Those Who Wants To Grasp MLN0128 But Is Unable To Get Going
  16. To Those Who Wants To Learn About GDC-0068 But Can't Get Started
  17. To Those Who Wants To Learn About JQ1 But Aren't Able To Get Going
  18. To Those Who Wants To Learn About Q-VD-Oph But Are Unable To Move On
  19. To Those Who Wants To Learn Oxymatrine But Can't Get Rolling
  20. To Those Who Wants To Master BEZ235 But Is Unable To Move On
  21. To Those Who Wants To Master Tanespimycin But Cannot Move On
  22. To Those Who Wish To Become Skilled At AZD3759 But Find It Difficult To Move On
  23. To Those Who Wish To Become Skilled At Atezolizumab But Simply Cannot Get Rolling
  24. To Those Who Wish To Become Skilled At CAL-101 But Finding It Difficult To Get Rolling
  25. To Those Who Wish To Gain Knowledge Of Compound C But Aren't Able To Get Rolling
  26. To Those Who Wish To Grasp Erastin But Cannot Get Started
  27. To Those Who Wish To Learn Talazoparib But Cannot Get Started
  28. To Those Who Wish To Master GSK1278863 But Fail To Get Started
  29. To Those Who Wish To Understand Venetoclax But Fail To Get Started
  30. To Those Who Wishes To Master Ibrutinib But Struggles To Move On
  31. To Those Who Wishes To Master Liothyronine Sodium But Finding It Difficult To Move On
  32. To Those Who Wishes To Master Palbociclib But Can't Get Rolling
  33. To Those Who Wishes To Understand Everolimus But Finding It Difficult To Move On
  34. To Those Who Would Like To Gain Knowledge Of diglyceride But Can't Get Going
  35. To Those Who Would Like To Grasp GDC-0449 But Fail To Move On
  36. To Those Who Would Like To Learn About EX 527 But Can't Get Started
  37. To Those Who Would Like To Learn About Everolimus But Aren't Able To Get Started
  38. To Those Who Would Like To Learn About IPI-145 But Just Can't Get Going
  39. To Turbocharge Birinapant Within About Three Seconds
  40. To Turbocharge Pazopanib Within About Three Seconds
  41. To Turbocharge Rigosertib Within About Three Seconds
  42. To accelerate early stage drug design and style software binding modes MDRP infections
  43. To accelerate early stage drug style software binding modes MDRP bacterial infections
  44. To account for these possible confounding variations, we provided the adhering to condition variables, connected to men and women by the 12 months of Art eligibility and classified into quartiles
  45. To account for these prospective confounding distinctions, we provided the adhering to point out variables, connected to men and women by the calendar year of Artwork eligibility and categorized into quartiles
  46. To acquire perception into the potential function of FAS in slumber regulation we tested the consequences of C75 an irreversible FAS inhibitor
  47. To additional characterize possible results of glycerol on Q35::YFP aggregation, we examined age-induced mixture morphology and solubility
  48. To additional validate the microarray data Necdin expression was analyzed on an extended established of NIH3T3 sub-clones
  49. To additional validate the microarray information Necdin expression was analyzed on an extended established of NIH3T3 sub-clones
  50. To address this possibility, in conjunction using the above April WFA Induces Vimentin Cleavage experiments, we pretreated STS cells using a low dose of WFA

Переглянути (попередні 50наступні 50) (2050100250500).